Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Priority to CR6543ApriorityCriticalpatent/CR6543A/en
Publication of CR6543ApublicationCriticalpatent/CR6543A/en
Polysaccharides And Polysaccharide Derivatives
(AREA)
Medicinal Preparation
(AREA)
Abstract
Se refiere a un complejo de eletriptan y a sulfobutileter-beta-ciclodextrina o a sales farmaceuticamente aceptables de los msimos, y a procedimientos para la preparacion de tal complejo y a uso de los mismos.It refers to a complex of eletriptan and sulfobutylether-beta-cyclodextrin or pharmaceutically acceptable salts thereof, and to procedures for the preparation of such complex and use thereof.
COMPOUNDS DERIVED FROM PIRAZOLO [4,3-d] PYRIMIDINE; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; PREPARATION PROCEDURE AND ITS USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HYPERTENSION.
USE OF COMPOUNDS OF 1-AMINO-5-PHENYLPENTANE-3-OL AND / OR 1-AMINO-6-PHENYLHEXAN-3-OL FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTAGONIST EFFECT OF N-METHYL-D-ASPARTATE- (NMDA)